AsortinoBeta
Medpace Holdings, Inc. logo

MEDPMedpace Holdings, Inc.

NASDAQStockHealthcareDiagnostics & Research🇺🇸 United StatesISIN US58506Q1094medpace.com
$591.290.35%
NASDAQ · at close Sep 4, 2026
Tokenized by
Reality logo
1 issuerOn
Arbitrum One logoMorph logo
2 chains

Chart data are delayed by 15 minutes.

1D0.35%
1M+2.82%
3M+28.91%
1Y+22.59%
3Y+116.19%
5Y+202.96%

Main metrics

$16.5B
34.72
$17.03
244.6K
1.15
$373.0052-week range$677.90

About MEDP

Medpace Holdings, Inc. is a global clinical research organization that provides outsourced clinical development services for biotechnology, pharmaceutical, and medical device companies. Medpace supports the full clinical trial lifecycle, from Phase I through Phase IV, with services that include study design, project management, clinical monitoring, regulatory affairs, data management, biostatistics, medical writing, pharmacovigilance, and post-marketing support. The company also offers specialized laboratory and trial support capabilities such as central laboratory services, bioanalytical testing, imaging core laboratory services, and cardiac safety assessments. Medpace serves clients across North America, Europe, Asia, South America, Africa, and Australia, playing a central role in helping sponsors run complex clinical programs and advance medical products through development.

Similar products

Agilent Technologies Inc. logo
ANYSE
$150.86+0.59%
Agilent Technologies Inc.
Backed Finance logoReality logoDinari Inc. logo
3 issuers · 13 chains
Charles River Laboratories International, Inc. logo
CRLNYSE
$288.501.65%
Charles River Laboratories International, Inc.
Reality logoDinari Inc. logo
2 issuers · 6 chains
Quest Diagnostics Incorporated logo
DGXNYSE
$237.140.94%
Quest Diagnostics Incorporated
Backed Finance logoReality logoDinari Inc. logo
3 issuers · 14 chains
Danaher Corp. logo
DHRNYSE
$207.661.60%
Danaher Corp.
Backed Finance logoReality logoDinari Inc. logo
3 issuers · 15 chains